MarketInOut Stock Screener Log In | Sign Up
 

Repligen Corp

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 09/21/2026 12:56
Repligen Corp stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,982.9 mln
Float56.27 mln
Earnings Date11/03/2026

EPS

0.73
Stretched

P / E

248
Bubble territory

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.74
Likely reliable

1-Year Forecast

189.48
Fairly priced

Relative Strength

90 / 100
Top performer

Business Description

Repligen is a Massachusetts-based company founded in 1981 that makes tools and equipment used in the production of biological medicines. Its products help drug manufacturers filter, purify, monitor, and refine biological compounds throughout the manufacturing process. The company sells to pharmaceutical firms, research laboratories, and contract manufacturers across North America, Europe, Asia, and other regions worldwide.

Key Fundamentals

EPS0.73
P/E248
ROE1.98
RPS13.94
ROIC2.46
ROA1.42
Interest Cover2.95
EBITDA, mln172
EV / EBITDA57.26
EV / EBIT132
Revenue, mln785
EV / Revenue12.52

Quote Details

Last 180.61
Change 3.72 (2.1%)
Open 176.89
Volume 357,512
Turnover 64,570,244
Average Volume 941,327

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio1.40
Current Ratio9.05
Price / Book4.71
Price / Tangible Book15.29
Price / Cash Flow73.96
Price / Free Cash Flow90.57
Debt / Equity0.33
Price / Sales12.71
PEG Ratio1.76

Financial Strength

Altman Z-Score8.13
Piotroski F-Score 8 / 9
Beneish M-Score-2.74
Price to Intrinsic Value4.04
Price to Graham Number7.80
1-Year Target Price189.48
Shiller PE Ratio156
Short Ratio6.73
Short % of Float11.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.51% 87 / 100   
1 Month 0.18% 61 / 100   
2 Months 38.3% 94 / 100   
6 Months 58.6% 92 / 100   
1 Year 45.21% 88 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us